Abbott tries to throw up roadblock to Humira biosim

While Pfizer ($PFE) was reporting a 71% drop in U.S. Lipitor sales and plotting its next spinoff move, Abbott Laboratories ($ABT) was working to shore up its own breakup plans by protecting its pharma…
Read the full story: News